AHR and cancer: Additionally, the authors performed a pan-cancer analysis which revealed high AhR expression in tumor-infiltrating immune cells, where AhR antagonism with a novel compound (BAY-2416964 (91)), see section below) showed promising potential in restoring immune cell function and enhancing antigen-specific cytotoxic T cell responses (90).